Litcius/Paper detail

Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

Elisabeth B. Stougaard, Peter Rossing, David Z.I. Cherney, Dorte Vistisen, Frederik Persson

2022Journal of Diabetes and its Complications14 citationsDOI

Topics & Concepts

MedicineType 2 diabetesDiabetes mellitusDiseaseIntensive care medicineCotransporterInternal medicineEndocrinologySodiumOrganic chemistryChemistryDiabetes Treatment and ManagementPancreatic function and diabetesDiabetes and associated disorders
Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines | Litcius